The long-term neurodevelopmental outcomes of toddlers with SARS-CoV-2 infection in the neonatal period: a prospective observational study.

Ezgi Yangın ErgonSenem Alkan OzdemirSinem Akbay AkMeltem YenilmezBuse SoysalOğuz Han KalkanlıŞebnem ÇalkavurTülin Gokmen Yıldırım

Published in: Italian journal of pediatrics (2024)

SARS-CoV-2-positive neonates revealed lower PDI scores and greater MDPs at 18th-24th months. The effect is most noticeable in Delta variant. Longer-term examination of neurodevelopmental outcomes and reevaluation of these children between the ages of 5 and 12 are critical.

Keyphrases

sars cov
respiratory syndrome coronavirus
young adults
preterm infants
single cell
low birth weight
type diabetes
metabolic syndrome
skeletal muscle
adipose tissue
insulin resistance
coronavirus disease
weight loss